LIN28A

Protein lin-28 homolog A · Q9H9Z2 · LIN28A on Sugi Atlas →

3,140 patent compounds predicted against LIN28A, 2,107 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL3324591 SCHEMBL3324591 0.60 2/20
SCHEMBL497135 SCHEMBL497135 0.58 2/20
SCHEMBL497311 SCHEMBL497311 0.48 2/20
SCHEMBL3882266 SCHEMBL3882266 0.44 2/20
SCHEMBL3326999 SCHEMBL3326999 0.42 2/20
SCHEMBL5147785 SCHEMBL5147785 0.41 2/20
SCHEMBL3882238 SCHEMBL3882238 0.39 2/20
SCHEMBL231092 SCHEMBL231092 1.00 1/20
SCHEMBL3475782 SCHEMBL3475782 1.00 1/20
SCHEMBL6864020 SCHEMBL6864020 0.85 1/20
SCHEMBL7107996 SCHEMBL7107996 0.84 1/20
SCHEMBL138261 SCHEMBL138261 0.83 1/20
SCHEMBL343596 SCHEMBL343596 0.81 1/20
SCHEMBL5562538 SCHEMBL5562538 0.81 1/20
SCHEMBL6864949 SCHEMBL6864949 0.81 1/20
SCHEMBL2903674 SCHEMBL2903674 0.79 1/20
SCHEMBL3626637 SCHEMBL3626637 0.79 1/20
SCHEMBL6864610 SCHEMBL6864610 0.79 1/20
SCHEMBL57060 SCHEMBL57060 0.78 1/20
SCHEMBL230051 SCHEMBL230051 0.78 1/20

Clinical trials — most relevant to LIN28A by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Clinical Trial of SB-509 in Subjects With Amyotrophic Lateral Sclerosis (ALS) PHASE2COMPLETED
Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria PHASE2COMPLETED
Induced Pluripotent Stem Cell Derived Exosomes for the Treatment of Atopic Dermatitis EARLY_PHASE1UNKNOWN
Impact of IL-28B rs12979860 and rs4803217 Gene Polymorphisms Associated With miRNAs Deregulation on HCV-related Hepatocellular Carcinoma nanUNKNOWN
Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases nanRECRUITING
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN
Impact of Weight Loss on the Human Sperm Epitranscriptome nanACTIVE_NOT_RECRUITING
Genomic Imprinting Testing for Diagnosis of Bladder Cancer nanUNKNOWN
Genetic Clues to Chordoma Etiology: A Protocol to Identify Sporadic Chordoma Patients for Studies of Cancer-Susceptibility Genes nanACTIVE_NOT_RECRUITING
Lung Cancer Diagnosis by Detecting Epigenetic Imprinting Alterations in Bronchoalveolar Lavage nanUNKNOWN
Scottish Advanced Fetal Research Study nanRECRUITING
miR-155 Expression in Episodic and Chronic Migraine nanUNKNOWN
Role of Specific microRNAs in Cluster Headache nanRECRUITING
Maternal Hypertriglyceridaemia Study nanUNKNOWN
Search for Bovine miRNA Transference to Humans nanCOMPLETED
The Relationship Between The Differential Expression Of FosB Protein In Laryngeal Cancer Tissues And Clinical Prognosis nanNOT_YET_RECRUITING
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Risk of HCC in Cirrhotic Patients Post DAAs Ttt nanUNKNOWN
Family Study of Head and Neck Cancers in Taiwan nanCOMPLETED
MicroRNAs and Cytokines in Peri-Implantitis Tissue nanUNKNOWN
Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients nanRECRUITING
Model to Predict pCR and IrAEs in Early Stage Non-small Cell Lung Cancer nanUNKNOWN
Role of Piwi-protein Interacting RNA, miRNA-194 and Amino Acids in Patients With Prostate Cancer nanUNKNOWN
Cytomegalovirus (CMV) MicroRNA Expression in Vivo and Immune Evasion Correlates nanCOMPLETED
New Signaling Pathway Targeting Systemic Lupus Erythematosus nanUNKNOWN
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Derivation of New Human Embryonic Stem Cell Lines: Identification of Instructive Factors for Germ Cells Development nanUNKNOWN
microRNA Profile in Early-stage Cervical Cancer nanCOMPLETED
Research on Effects of Acute Consumption of Nuts in Obese Diabetic Women nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a LIN28A binder may also engage these)

ProteinNameSimilarity
Q8K3Y3 1.000 Q8K3Y3 →
Q45KJ5 0.990 Q45KJ5 →
Q45KJ6 0.983 Q45KJ6 →
Q6ZN17 0.981 Q6ZN17 →
Q803L0 0.978 Q803L0 →
Q45KJ4 0.973 Q45KJ4 →
Q8AVK2 0.967 Q8AVK2 →
Q5EB47 0.963 Q5EB47 →
Q8JHC4 0.950 Q8JHC4 →
Q99NA9 0.947 Q99NA9 →
Q5XI70 0.947 Q5XI70 →
Q3V038 0.943 Q3V038 →
PML Protein PML 0.943 landscape →
Q96NA8 0.942 Q96NA8 →
A4Q9F4 0.942 A4Q9F4 →
Q5JSP0 0.941 Q5JSP0 →
Q8NHH1 0.941 Q8NHH1 →
Q8CE64 0.940 Q8CE64 →
Q80VL1 0.940 Q80VL1 →
Q9BYE7 0.939 Q9BYE7 →
Q9Y2W6 0.939 Q9Y2W6 →
O94888 0.938 O94888 →
Q92623 0.938 Q92623 →
Q5REY7 0.938 Q5REY7 →
Q5R5T1 0.938 Q5R5T1 →
Q8N554 0.937 Q8N554 →
METTL16 RNA N(6)-adenosine-methyltransferase METTL16 0.937 landscape →
Q9BT49 0.936 Q9BT49 →
Q922P9 0.936 Q922P9 →
Q6P9L4 0.936 Q6P9L4 →